Flagship Harbor Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-349
Closed -$37K 1119
2025
Q4
$37K Buy
+349
New +$40.5K ﹤0.01% 1149
2020
Q4
Sell
-35
Closed -$1K 856
2020
Q3
$1K Sell
35
-84
-71% -$4.31K ﹤0.01% 1807
2020
Q2
$5K Buy
119
+83
+231% +$4.48K ﹤0.01% 1564
2020
Q1
$2K Sell
36
-189
-84% -$10.9K ﹤0.01% 1637
2019
Q4
$12K Buy
225
+1
+0.4% +$54 ﹤0.01% 1273
2019
Q3
$11K Sell
224
-496
-69% -$24.9K ﹤0.01% 1252
2019
Q2
$36K Sell
720
-122
-14% -$5.92K 0.01% 869
2019
Q1
$39K Sell
842
-108
-11% -$5.47K 0.01% 827
2018
Q4
$46K Buy
950
+372
+64% +$21.2K 0.01% 738
2018
Q3
$36K Buy
578
+368
+175% +$22.4K 0.01% 916
2018
Q2
$11K Buy
+210
New +$10.5K ﹤0.01% 1320

Other funds holding EHC

Flagship Harbor Advisors's EHC Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 349 shares — an estimated $37K sold.

Flagship Harbor Advisors first reported a position in EHC in Q2 2018 and held it in 11 quarters. The position peaked at $46K in Q4 2018. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 349 Encompass Health shares in Q1 2026, an estimated $37K.
  • Flagship Harbor Advisors first reported a position in Encompass Health in Q2 2018 and held it in 11 quarters.
  • Flagship Harbor Advisors's Encompass Health position peaked at $46K in Q4 2018.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.